Biosysen Limited (HKG:1355)

Biosysen Balance Sheet

Financials in millions HKD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1.09	2.44	13.86	2.21	2.43	14.3
Trading Asset Securities	-	-	-	-	3.91	2.75
Cash & Short-Term Investments	1.09	2.44	13.86	2.21	6.35	17.05
Cash Growth	-88.85%	-82.37%	525.88%	-65.12%	-62.76%	-14.64%
Accounts Receivable	2.75	5.46	0.97	1.07	15.96	4.79
Other Receivables	-	0.39	0.91	1.98	3.42	3.06
Receivables	2.75	5.86	1.88	3.05	19.38	7.84
Inventory	0.21	0.37	0.4	0.38	0.34	0.38
Prepaid Expenses	8.07	1.02	0.57	0.33	0.71	1.16
Other Current Assets	0.23	10.28	1.09	3.25	2.64	0.04
Total Current Assets	12.33	19.97	17.8	9.22	29.43	26.47
Property, Plant & Equipment	36.58	40.89	54.05	111.97	159.22	204.97
Goodwill	-	-	-	-	1.96	2.06
Long-Term Deferred Tax Assets	-	-	-	2.91	3.4	2.05
Other Long-Term Assets	1.31	19.59	3.21	3.23	2.17	4.63
Total Assets	71.51	80.44	75.05	127.32	196.17	240.18

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	4.06	3.06	2.17	1.53	0.99	1.65
Accrued Expenses	16.54	10.35	8.27	8.32	6.63	3.43
Short-Term Debt	50.57	43.57	28.57	27.47	27.47	22.77
Current Portion of Leases	13.69	22.45	29.77	25.95	22.57	25.03
Current Income Taxes Payable	1.3	1.42	1.71	2.21	2.67	2.08
Current Unearned Revenue	-	-	0.07	0.23	0.19	0.3
Other Current Liabilities	-	5.81	2.71	15.71	30.24	30.6
Total Current Liabilities	86.16	86.65	73.27	81.41	90.76	85.85
Long-Term Leases	37.65	96.17	106.65	128.18	125.82	155.83
Other Long-Term Liabilities	0.56	0.53	0.48	0.48	0.46	0.48
Total Liabilities	124.37	183.34	180.4	210.06	217.04	242.16

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	11.93	11.93	5.38	4.48	4.48	4.48
Additional Paid-In Capital	320.57	320.57	275.67	261.58	261.58	261.58
Retained Earnings	-353.8	-374.95	-331.42	-310.3	-272.12	-264.33
Comprehensive Income & Other	6.92	7.2	8.01	7.89	8.24	10.59
Total Common Equity	-14.39	-35.25	-42.36	-36.35	2.18	12.32
Minority Interest	-38.48	-67.65	-63	-46.39	-23.05	-14.3
Shareholders' Equity	-52.86	-102.9	-105.35	-82.74	-20.87	-1.97
Total Liabilities & Equity	71.51	80.44	75.05	127.32	196.17	240.18

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	101.91	162.19	164.99	181.6	175.86	203.62
Net Cash (Debt)	-100.82	-159.74	-151.14	-179.38	-169.51	-186.58
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.09	-0.17	-0.27	-0.40	-0.38	-0.42
Filing Date Shares Outstanding	1,193	1,193	538.03	448.36	448.36	448.36
Total Common Shares Outstanding	1,193	1,193	538.03	448.36	448.36	448.36
Working Capital	-73.82	-66.68	-55.47	-72.19	-61.34	-59.38
Book Value Per Share	-0.01	-0.03	-0.08	-0.08	0.00	0.03
Tangible Book Value	-14.39	-35.25	-42.36	-36.35	0.22	10.26
Tangible Book Value Per Share	-0.01	-0.03	-0.08	-0.08	0.00	0.02
Machinery	-	32.37	19.89	20.53	20.69	21.64
Leasehold Improvements	-	52.8	52.68	54.07	54.23	55.94

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 13, 2026

Data Sources Report a data error